HeartFlow, Inc. (HTFL)
NASDAQ: HTFL · Real-Time Price · USD
24.83
+0.33 (1.35%)
At close: Apr 2, 2026, 4:00 PM EDT
24.99
+0.16 (0.64%)
After-hours: Apr 2, 2026, 7:47 PM EDT

Company Description

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide.

Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart’s arteries.

The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies.

Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests.

HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009.

The company was incorporated in 2007 and is headquartered in Mountain View, California.

HeartFlow, Inc.
HeartFlow logo
CountryUnited States
Founded2007
IPO DateAug 8, 2025
IndustryHealth Information Services
SectorHealthcare
Employees843
CEOJohn Farquhar

Contact Details

Address:
331 E. Evelyn Avenue
Mountain View, California 94041
United States
Phone650 241 1221
Websiteheartflow.com

Stock Details

Ticker SymbolHTFL
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$19.00
CIK Code1464521
CUSIP Number42238D107
ISIN NumberUS42238D1072
Employer ID26-0506743
SIC Code3841

Key Executives

NamePosition
John C.M. FarquharPresident, Chief Executive Officer and Director
Vikram Verghese C.F.A.Chief Financial Officer
Dr. Campbell D.K. Rogers FACC, M.D.Chief Medical Officer and Executive Vice President
Dr. John Henry Stevens M.D.Co-Founder
Kathleen CareySenior Vice President of Operations
Mhairi L. JonesChief Accounting Officer
Justin CambraChief Technology Officer
Nicholas S. LaudicoVice President of Investor Relations
Angela Ahmad J.D.Chief Legal and Compliance Officer
Shivanth BhaskaranSenior Vice President of Marketing, International Sales and Customer Success

Latest SEC Filings

DateTypeTitle
Apr 1, 2026144Filing
Mar 31, 2026SCHEDULE 13GFiling
Mar 19, 2026144Filing
Mar 18, 2026S-8Securities to be offered to employees in employee benefit plans
Mar 18, 202610-KAnnual Report
Mar 18, 20268-KCurrent Report
Mar 18, 2026144Filing
Mar 10, 2026144Filing
Mar 5, 2026SCHEDULE 13G/AFiling
Mar 5, 2026144Filing